logologo
QuantliQuantli

Natera Inc

NTRA

NASDAQ

Biotechnology

$309.93

USD

-0.85 (-0.27%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $44.64B

Volume 1.3M

Price Target

$245.00$360.00

USD

The 9 analysts offering 1-year price forecasts have a max estimate of $360.00 and a min estimate of $245.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$302.22

+$50.2 vs prior

Implied Upside

-2.5%

+16.2% vs prior

Analyst Covering

9

+3 vs prior period

Consensus

Buy

Improved vs prior

Signal Quality

Consensus Freshness

60%

A mix of recent and older ratings shape this consensus

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$7.78 Gap

Median $310.00 vs avg $302.22 - a few cautious outliers are pulling the average down

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

8 Buy

1 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

8

Hold

1

Sell

0

Strong Sell

0

9 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Subbu Nambi

Guggenheim

Buy

Maintained

4 days ago

Plus
Plus
Plus

Mark Massaro

BTIG

Buy

Maintained

1 week ago

Plus
Plus
Plus

Daniel Markowitz

Evercore ISI Group

Buy

Maintained

1 week ago

Plus
Plus
Plus

Kyle Mikson

Canaccord Genuity

Buy

Maintained

4 weeks ago

Plus
Plus
Plus

Eve Burstein

Bernstein

Buy

Resumed

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

RVMD

Revolution Medicines Inc

$203.71

+0.8%

AMGN

Amgen Inc

$415.21

-0.6%

BIIB

Biogen Inc

$209.83

-0.4%

ALNY

Alnylam Pharmaceuticals Inc

$228.65

+0.7%

VRTX

Vertex Pharmaceuticals Inc

$505.75

-2.1%

MRNA

Moderna Inc

$63.32

-0.5%

REGN

Regeneron Pharmaceuticals Inc

$803.48

-0.3%

GILD

Gilead Sciences, Inc

$138.36

+0.2%

INCY

Incyte Corp

$120.16

-0.3%

INSM

Insmed Inc

$123.74

-2.0%